Lubna Siddique
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lubna Siddique has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Latifur Rehman
Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China
2 shared publications - Najib Ullah Khan
Institute of Biotechnology and Genetic Engineering, KPK Agricultural University, Peshawar, Pakistan
2 shared publications Aqib Iqbal
Institute of Biotechnology and Genetic Engineering, Khyber Pakhtunkhwa Agricultural University, Peshawar, Pakistan
1 shared publication- Aqib Iqbal
Institute of Biotechnology and Genetic Engineering, KPK Agricultural University, Peshawar, Pakistan
1 shared publication - Farzana Rashid
Lahore College for Women University, Lahore, Pakistan
1 shared publication Ijaz Ali
Institute of Biotechnology and Genetic Engineering, Khyber Pakhtunkhwa Agricultural University, Peshawar, Pakistan
1 shared publication
Latest Publications
- Open Access
- 11 June 2011
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 296
Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa
Hepatitis C is an infectious disease, caused by blood borne pathogen; the Hepatitis C Virus. In this study we analyzed blood samples collected from various risk groups for the prevalence of anti-HCV and active HCV infection with the help of Immunochromtographic tests and nested PCR. The prevalence of active HCV infection among the high risk groups was 15.57% (26/167). The prevalence of HCV in individual risk groups was 15%, 28%, 8%, 14.28% and 14.28% in the case of thalassemics, dialysis, major surgery group, dental surgery group and injection drug users respectively. Our analysis reveals the fact that health care facilities in the Khyber Pakhtunkhwa province of Pakistan are contributing a great deal towards the spread of HCV infection.
- 11 June 2011
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 296
Open AccessPrevalence of HCV among the high risk groups in Khyber Pakhtunkhwa
Hepatitis C is an infectious disease, caused by blood borne pathogen; the Hepatitis C Virus. In this study we analyzed blood samples collected from various risk groups for the prevalence of anti-HCV and active HCV infection with the help of Immunochromtographic tests and nested PCR. The prevalence of active HCV infection among the high risk groups was 15.57% (26/167). The prevalence of HCV in individual risk groups was 15%, 28%, 8%, 14.28% and 14.28% in the case of thalassemics, dialysis, major surgery group, dental surgery group and injection drug users respectively. Our analysis reveals the fact that health care facilities in the Khyber Pakhtunkhwa province of Pakistan are contributing a great deal towards the spread of HCV infection.
- Open Access
- 1 April 2011
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 154
Prevalence of active HCV infection among the blood donors of Khyber Pakhtunkwa and FATA region of Pakistan and evaluation of the screening tests for anti-HCV
Hepatitis C is a fatal liver disease caused by the hepatitis C virus. In this study, blood donors, from various districts of the KPK province and the federally administered tribal area (FATA) of Pakistan were tested for anti-HCV antibodies and HCV RNA by ICT (Immuno-chromatographic test), ELISA and RT-PCR. Out of the 7148 blood donors, 224 (3.13%) were positive for anti-HCV antibodies by ICT, 135 (1.89%) by ELISA while 118 (1.65%) blood donors had active HCV infection as detected by RT-PCR. We suggest that ELISA should be used for anti-HCV screening in public sector hospitals and health care units.
- 1 April 2011
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 154
Open AccessPrevalence of active HCV infection among the blood donors of Khyber Pakhtunkwa and FATA region of Pakistan and evaluation of the screening tests for anti-HCV
Hepatitis C is a fatal liver disease caused by the hepatitis C virus. In this study, blood donors, from various districts of the KPK province and the federally administered tribal area (FATA) of Pakistan were tested for anti-HCV antibodies and HCV RNA by ICT (Immuno-chromatographic test), ELISA and RT-PCR. Out of the 7148 blood donors, 224 (3.13%) were positive for anti-HCV antibodies by ICT, 135 (1.89%) by ELISA while 118 (1.65%) blood donors had active HCV infection as detected by RT-PCR. We suggest that ELISA should be used for anti-HCV screening in public sector hospitals and health care units.